Copenhagen City Heart Study, Epidemiological Research Unit, Copenhagen University Hospital, Bispebjerg, Denmark.
J Hypertens. 2010 May;28(5):1091-6. doi: 10.1097/HJH.0b013e328335fa81.
The present study focused on trend in hypertension control and on determinant factors that may influence efficacy in antihypertensive therapy. Two measures of treatment efficacy were used: population blood pressure and the relative frequency of effectively treated patients (blood pressure <140/90 mmHg).
Copenhagen City Heart Study is a prospective longitudinal epidemiological study with 25 years of follow-up. The study population were treated hypertensive patients. The blood pressure measurement was fully standardized and measurement method was unchanged throughout the observation period. A questionnaire was completed by the participants and double-checked by the technicians.
The number of treated hypertensive patients increased considerably and hypertension control increased from 21 to 26%. Pretreatment SBP was stable in the observation period indicating that start-to-treat practice was stable. Treated SBP decreased from 157.9 to 148.7 mmHg. Four determinant factors were significant. Men presented a higher pretreatment SBP before starting antihypertensive medication. Elderly patients presented a higher pretreatment SBP and were poorly treated as compared with younger hypertensive patients. Obesity was associated with a high threshold SBP. The fourth factor was diagnosis. Patients with myocardial infarction were better treated in last surveys than patients from other diagnosis groups. Treated DBP was stable.
Hypertension treatment efficacy is improving but still far from acceptable. The evaluation of determinant factors identified four areas that need special attention: men, elderly and obese hypertensive patients. The fourth factor is diagnosis. The results may indicate a beneficial effect of systematic control of hypertensive patients during a limited time after a myocardial infarction.
本研究主要关注高血压控制的趋势以及可能影响降压治疗效果的决定因素。采用了两种治疗效果衡量标准:人群血压和有效治疗患者的相对频率(血压<140/90mmHg)。
哥本哈根城市心脏研究是一项具有 25 年随访的前瞻性纵向流行病学研究。研究人群为接受治疗的高血压患者。血压测量完全标准化,且在整个观察期间测量方法保持不变。参与者填写问卷,并由技术人员进行双重检查。
接受治疗的高血压患者数量显著增加,高血压控制率从 21%提高到 26%。在观察期间,预处理 SBP 保持稳定,表明开始治疗的做法保持稳定。治疗 SBP 从 157.9mmHg 降至 148.7mmHg。有四个决定因素具有显著意义。男性在开始抗高血压药物治疗前的预处理 SBP 更高。与年轻高血压患者相比,老年患者的预处理 SBP 更高,治疗效果较差。肥胖与较高的阈值 SBP 相关。第四个因素是诊断。与其他诊断组的患者相比,心肌梗死患者在最近的调查中治疗效果更好。治疗 DBP 保持稳定。
高血压治疗效果正在改善,但仍远未达到可接受的水平。对决定因素的评估确定了四个需要特别关注的领域:男性、老年和肥胖高血压患者。第四个因素是诊断。结果可能表明在心肌梗死后有限的时间内对高血压患者进行系统控制可能会产生有益的效果。